Affinity purification of cross-ß fibrils using immobilized thioflavin

使用固定化硫代黄素对交叉原纤维进行亲和纯化

基本信息

  • 批准号:
    10646061
  • 负责人:
  • 金额:
    $ 18.43万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-04-01 至 2025-03-31
  • 项目状态:
    未结题

项目摘要

Project Summary Neurodegenerative diseases such as Alzheimer’s disease cause a significant socioeconomic burden. These diseases manifest as protein plaques in the brain tissues. As of today, there are no available drugs to treat or prevent these diseases. For rational drug design, it is essential to understand the atomic details of the proteins involved in these plaques. To achieve this, researchers utilize structural biology methods such as electron cryomicroscopy (cryoEM), nuclear magnetic resonance, and X-ray crystallography. Neuropathologists isolate these plaques from post-mortem patient brain tissues and assess the disease for the presence of plaques. Then the samples are subjected to structural studies. Since 2017, a significant number of atomic structures of the protein molecules involved in the plaques have been reported. However, isolation of proteins from tissue samples is a bottleneck due to low yield, differences in the protein structures, and the presence of contaminants. The proteins in the plaques have a distinct arrangement in that they form a β-strand conformation and stack on top of each other along a helical axis. This arrangement gives rise to a unique property – they bind to molecules such as thioflavin and exhibit characteristic fluorescence emission. Such a property enables researchers to know the presence of protein plaques and quantify them in cellular models. Here, we propose to utilize the specificity of thioflavin to protein filaments of neuropathological plaques as a new method of plaque purification. The method combines the specificity of thioflavin to the protein filaments and affinity-based purification methods that are widely used to purify proteins. We propose that our method would enable researchers to extract and isolate protein filaments from brain tissues with much improved yields, fewer contaminants, and shorter processing times.
项目总结

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Wen Jiang其他文献

Wen Jiang的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Wen Jiang', 18)}}的其他基金

Engineering In Vivo Chimeric Antigen Receptor Macrophages (CARMs) using mRNA-exosomes for Cancer Immunotherapy
使用 mRNA-外泌体工程体内嵌合抗原受体巨噬细胞 (CARM) 用于癌症免疫治疗
  • 批准号:
    10740743
  • 财政年份:
    2023
  • 资助金额:
    $ 18.43万
  • 项目类别:
A Phagocytosis Modulating Nanomedicine for Targeted Breast Cancer Immunotherapy
用于靶向乳腺癌免疫治疗的吞噬调节纳米药物
  • 批准号:
    10381905
  • 财政年份:
    2021
  • 资助金额:
    $ 18.43万
  • 项目类别:
Therapeutic targeting of multiple glioblastoma phagocytosis checkpoints using a novel bispecific antibody
使用新型双特异性抗体靶向治疗多个胶质母细胞瘤吞噬检查点
  • 批准号:
    10428596
  • 财政年份:
    2021
  • 资助金额:
    $ 18.43万
  • 项目类别:
Therapeutic targeting of multiple glioblastoma phagocytosis checkpoints using a novel bispecific antibody
使用新型双特异性抗体靶向治疗多个胶质母细胞瘤吞噬检查点
  • 批准号:
    10212046
  • 财政年份:
    2021
  • 资助金额:
    $ 18.43万
  • 项目类别:
Therapeutic targeting of multiple glioblastoma phagocytosis checkpoints using a novel bispecific antibody
使用新型双特异性抗体靶向治疗多个胶质母细胞瘤吞噬检查点
  • 批准号:
    10609925
  • 财政年份:
    2021
  • 资助金额:
    $ 18.43万
  • 项目类别:
Renal Cell Carcinoma Surveillance by Immuno-Lipoplex Nanoparticle Platform
通过免疫脂质体纳米颗粒平台监测肾细胞癌
  • 批准号:
    10544876
  • 财政年份:
    2020
  • 资助金额:
    $ 18.43万
  • 项目类别:
Renal Cell Carcinoma Surveillance by Immuno-Lipoplex Nanoparticle Platform
通过免疫脂质体纳米颗粒平台监测肾细胞癌
  • 批准号:
    10044277
  • 财政年份:
    2020
  • 资助金额:
    $ 18.43万
  • 项目类别:
A Phagocytosis Modulating Nanomedicine for Targeted Breast Cancer Immunotherapy
用于靶向乳腺癌免疫治疗的吞噬调节纳米药物
  • 批准号:
    9805697
  • 财政年份:
    2019
  • 资助金额:
    $ 18.43万
  • 项目类别:
HBGA receptors in host cell entry and infection of norovirus
HBGA受体在诺如病毒进入宿主细胞和感染中的作用
  • 批准号:
    9182813
  • 财政年份:
    2014
  • 资助金额:
    $ 18.43万
  • 项目类别:
HBGA receptors in host cell entry and infection of norovirus
HBGA受体在诺如病毒进入宿主细胞和感染中的作用
  • 批准号:
    8967560
  • 财政年份:
    2014
  • 资助金额:
    $ 18.43万
  • 项目类别:

相似海外基金

A novel motility system driven by two classes of bacterial actins MreB
由两类细菌肌动蛋白 MreB 驱动的新型运动系统
  • 批准号:
    22KJ2613
  • 财政年份:
    2023
  • 资助金额:
    $ 18.43万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
The structural basis of plasmid segregation by bacterial actins
细菌肌动蛋白分离质粒的结构基础
  • 批准号:
    342887
  • 财政年份:
    2016
  • 资助金额:
    $ 18.43万
  • 项目类别:
    Operating Grants
The structural basis for plasmid segregation by bacterial actins
细菌肌动蛋白分离质粒的结构基础
  • 批准号:
    278338
  • 财政年份:
    2013
  • 资助金额:
    $ 18.43万
  • 项目类别:
    Operating Grants
Cytoplasmic Actins in Maintenance of Muscle Mitochondria
细胞质肌动蛋白在维持肌肉线粒体中的作用
  • 批准号:
    8505938
  • 财政年份:
    2012
  • 资助金额:
    $ 18.43万
  • 项目类别:
Differential Expression of the Diverse Plant Actins
多种植物肌动蛋白的差异表达
  • 批准号:
    7931495
  • 财政年份:
    2009
  • 资助金额:
    $ 18.43万
  • 项目类别:
Studies on how actins and microtubules are coordinated and its relevancy.
研究肌动蛋白和微管如何协调及其相关性。
  • 批准号:
    19390048
  • 财政年份:
    2007
  • 资助金额:
    $ 18.43万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Suppression of Arabidopsis Reproductive Actins
拟南芥生殖肌动蛋白的抑制
  • 批准号:
    6655612
  • 财政年份:
    2003
  • 资助金额:
    $ 18.43万
  • 项目类别:
Suppression of Arabidopsis Reproductive Actins
拟南芥生殖肌动蛋白的抑制
  • 批准号:
    6546977
  • 财政年份:
    2003
  • 资助金额:
    $ 18.43万
  • 项目类别:
Interaction of myosin with monomeric actins
肌球蛋白与单体肌动蛋白的相互作用
  • 批准号:
    5311554
  • 财政年份:
    2001
  • 资助金额:
    $ 18.43万
  • 项目类别:
    Priority Programmes
STRUCTURE/INTERACTIONS OF ACTINS AND ACTIN-BINDING PROTEIN
肌动蛋白和肌动蛋白结合蛋白的结构/相互作用
  • 批准号:
    6316669
  • 财政年份:
    2000
  • 资助金额:
    $ 18.43万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了